Polymorphism of ERCC2 Asp312Asn with lung cancer risk: Evidence from 20,101 subjects

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 1, 2014, Pages 50-56

  Tan, Xiang ^a   Wang, Yongyong ^a   Shi, Lijun ^a   Xian, Lei ^a   Guo, Jianji ^a   Liang, Guanbiao ^a   Chen, Mingwu ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; HIGH RISK POPULATION; HUMAN; LUNG CANCER; META ANALYSIS (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN;

ASPARAGINE; ASPARTIC ACID; CASE-CONTROL STUDIES; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84891846540     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0296     Document Type: Article

References (41)

1. Benhamou S, Sarasin A (2002) ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17:463-469.
2. Benhamou S, Sarasin A. (2005) ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161:1-14.
3. Butkiewicz D, Rusin M, Enewold L, et al. (2001) Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22:593-597.
4. Chang JS, Wrensch MR, Hansen HM, et al. (2008) Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 123:2095-2104.
5. De Ruyck K, Szaumkessel M, De Rudder I, et al. (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.Mutat Res 631:101-110.
6. Feng Z, Ni Y, Dong W, et al. (2012) Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-Analysis. Mol Biol Rep 39:57-69.
7. Hemminki K, Xu G, Angelini S, et al. (2001) XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis 22:1185-1188.
8. Hou SM, Fa lt S, Angelini S, et al. (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23:599-603.
9. Hu Z, Xu L, Shao M, et al. (2006) Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol Biomarkers Prev 15:1336-1340.
10. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90.
11. Jiang Z, Li C, Xu Y, et al. (2010) Associations between XPD polymorphisms and risk of breast cancer: a meta-Analysis. Breast Cancer Res Treat 123:203-212.
12. Kiyohara C, Yoshimasu K (2007) Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-Analysis. Int J Med Sci 4:59-71.
13. Liang G, Xing D, Miao X, et al. (2003) Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer 105:669-673.
14. Liao SG, Liu L, Wang Y, et al. (2012) XPD Asp312Asn polymorphism is a risk factor for prostate cancer. J Cancer Res Clin Oncol 138:1689-1695.
15. Lopez-Cima MF, Gonzalez-Arriaga P, Garc?a-Castro L, et al. (2007) Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer 7:162.
16. Manuguerra M, Saletta F, Karagas MR, et al. (2006) XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164:297-302.
17. Matullo G, Dunning AM, Guarrera S, et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27:997-1007.
18. Misra RR, Ratnasinghe D, Tangrea JA, et al. (2003) Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191:171-178.
19. Peters JL, Sutton AJ, Jones DR, et al. (2006) Comparison of two methods to detect publication bias in meta-Analysis. JAMA 295:676-680.
20. Popanda O, Schattenberg T, Phong CT, et al. (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25:2433-2441.
21. Qian B, Zhang H, Zhang L, et al. (2011) Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73:138-146.
22. Raaschou-Nielsen O, Srensen M, Overvad K, et al. (2008) Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 59:171-179.
23. Rohlfs RV, Weir BS. (2008) Distributions of Hardy-Weinberg equilibrium test statistics. Genetics 180:1609-1616.
24. Sakoda LC, Loomis MM, Doherty JA, et al. (2012) Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet 3:1-17.
25. Schaeffer L, Moncollin V, Roy R, et al. (1994) The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J 13:2388-2392.
26. Shen M, Berndt SI, Rothman N, et al. (2005) Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 116:768-773.
27. Spitz MR, Wu X, Wang Y, et al. (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61:1354-1357.
28. Vineis P, Manuguerra M, Kavvoura FK, et al. (2009) A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24-36.
29. Vogel U, Laros I, Jacobsen NR, et al. (2004) Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 546:65-74.
30. Wang F, Chang D, Hu FL, et al. (2008) DNA repair gene XPD polymorphisms and cancer risk: a meta-Analysis based on 56 case-control studies. Cancer Epidemiol Biomarkers Prev 17:507-517.
31. Weber CA, Salazar EP, Stewart SA, et al. (1990) ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J 9:1437-1447.
32. Xing D, Tan W, Wei Q, Lin D, et al. (2002) Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 38:123-129.
33. Yang Z, Wu Q, Shi Y, et al. (2012) Epidermal growth factor 61A G polymorphism is associated with risk of hepatocellular carcinoma: a meta-Analysis. Genet Test Mol Biomarkers 16:1086-1091.
34. Yin J, Vogel U, Ma Y, et al. (2007) A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population. Cancer Genet Cytogenet 175:47-51.
35. Yin QH, Liu C, Hu JB, et al. (2013) XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-Analysis of case-control studies. Asian Pac J Cancer Prev 14:231-236.
36. Yin Z, Su M, Li X, et al. (2009) ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females. J Exp Clin Cancer Res 28:153.
37. Youlden DR, Cramb SM, Baade PD (2008) The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol 3:819-831.
38. Zhang J, Qiu LX, Leaw SJ, et al. (2011) The association between XPD Asp312Asn polymorphism and lung cancer risk: a metaanalysis including 16,949 subjects. Med Oncol 28:655-60.
39. Zhou M, Wan HY, Gao BL (2002) Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 62: 1377-1381.
40. Zhou M, Wan HY, Gao BL, et al. (2012) Genetic polymorphisms of XPD and CDA and lung cancer risk. Oncol Lett 4:247-251.
41. Zienolddiny S, Campa D, Lind H, et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27:560-567.